Putting the brakes on cardiac hypertrophy: exploiting the NO-cGMP counter-regulatory system.
about
Heart failure with preserved ejection fraction: emerging drug strategiesThe CXCL10/CXCR3 Axis and Cardiac Inflammation: Implications for Immunotherapy to Treat Infectious and Noninfectious Diseases of the HeartArginase induction and activation during ischemia and reperfusion and functional consequences for the heartRight Ventricular Adaptation Is Associated with the Glu298Asp Variant of the NOS3 Gene in Elite Athletes.Pivotal effects of phosphodiesterase inhibitors on myocyte contractility and viability in normal and ischemic hearts.Three 4-letter words of hypertension-related cardiac hypertrophy: TRPC, mTOR, and HDAC.New take on the role of angiotensin II in cardiac hypertrophy and fibrosis.The Impact of Overnutrition on Insulin Metabolic Signaling in the Heart and the KidneyCardiac insulin resistance and microRNA modulators.Adaptive mechanisms to compensate for overnutrition-induced cardiovascular abnormalities.In Vivo Protective Effects of Diosgenin against Doxorubicin-Induced Cardiotoxicity.Targeting calcineurin and associated pathways in cardiac hypertrophy and failure.Relaxin and atrial natriuretic peptide pathways participate in the anti-fibrotic effect of a melon concentrate in spontaneously hypertensive rats.The angiotensin II type 2 receptor in cardiovascular disease.Angiotensin II type 2 receptor gene polymorphisms in cardiovascular disease.Molecular pathways underlying cardiac remodeling during pathophysiological stimulation.Role of Nitric Oxide, Nitric Oxide Synthase, Soluble Guanylyl Cyclase, and cGMP-Dependent Protein Kinase I in Mouse Stem Cell Cardiac Development.alpha1G-dependent T-type Ca2+ current antagonizes cardiac hypertrophy through a NOS3-dependent mechanism in miceDetection of left ventricular hypertrophy in rats administered a peroxisome proliferator-activated receptor alpha/gamma dual agonist using natriuretic peptides and imaging.Pressure overload-induced hypertrophy in transgenic mice selectively overexpressing AT2 receptors in ventricular myocytes.Carperitide induces coronary vasodilation and limits infarct size in canine ischemic hearts: role of NO.Un-sweetening the Heart: Possible pleiotropic effects of SGLT2 inhibitors on cardio and cerebrovascular alterations in resistant hypertensive subjects.Aucubin protects against pressure overload-induced cardiac remodelling via β3-AR-nNOS cascades.Interaction between nitric oxide and renal α1-adrenoreceptors mediated vasoconstriction in rats with left ventricular hypertrophyin Wistar Kyoto rats.
P2860
Q24595118-B2426FB1-A255-4D4D-9FF0-A979A90A37E4Q28079006-0C7BF9C9-6707-424E-8B9E-0C08056DAF5EQ28081566-DD8CC42F-6EBA-4F39-9365-64E1904238B0Q31013454-EE98B6AE-5C36-4A59-9178-CCF506C852FEQ33552229-E809DE5F-B24D-4DD3-B027-C4CC79010BEDQ34969926-44595338-99BA-431B-B2E5-4C1DA6819D8CQ34993358-F621ACF2-BAE4-4691-97E3-811A2DC1A78AQ35005356-A844A4A2-DED3-4F90-AD43-ACB0FAF3ABA0Q35251097-D3B20902-A201-468C-BDAD-C1BFE2302E27Q35789287-05F8307C-D7BF-472A-8B05-90B3A66FC1AFQ35809052-F6105530-F6F2-4DCD-8498-32F0344DA9A8Q36268310-F08CA80C-8388-4644-9CFD-3BE103946F04Q36799613-F5C333AE-B9C1-47D8-8094-0A57EAA4FD3BQ37622575-3D59C092-8A90-426E-BC12-24A149DF83D4Q37622578-D512C99C-E6E3-4D9F-BF12-AEC881438536Q41855920-34DF851F-638E-4CF7-8C7D-EA35963472CCQ41862756-641B9B38-34F1-4C1D-BC6A-F342FB6DA2E4Q42690112-0BADA8B5-1A4E-4B7C-8F42-86C81806DFECQ43203756-693CBE0B-B509-4A83-AC1F-7B992B7E3095Q46820254-EA0090FF-E641-48AE-9762-D063F1646A93Q47176304-58D17918-FCC6-482A-A0DB-003D678CA194Q49550551-50CEB47F-5DAF-4AB4-9E01-CCFB8EBB3821Q49977036-82AB506F-CBEB-48AB-BEF6-C87770ACE8FDQ49980761-1FF0D880-5A7F-4C88-B552-1AE374C2EB11
P2860
Putting the brakes on cardiac hypertrophy: exploiting the NO-cGMP counter-regulatory system.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Putting the brakes on cardiac ...... GMP counter-regulatory system.
@ast
Putting the brakes on cardiac ...... GMP counter-regulatory system.
@en
type
label
Putting the brakes on cardiac ...... GMP counter-regulatory system.
@ast
Putting the brakes on cardiac ...... GMP counter-regulatory system.
@en
prefLabel
Putting the brakes on cardiac ...... GMP counter-regulatory system.
@ast
Putting the brakes on cardiac ...... GMP counter-regulatory system.
@en
P1433
P1476
Putting the brakes on cardiac ...... GMP counter-regulatory system.
@en
P2093
George W Booz
P304
P356
10.1161/01.HYP.0000156878.17006.02
P407
P577
2005-02-14T00:00:00Z